αA 66−80 peptide forms with age in the lens nucleus of humans and guinea pigs, and binds to αA-crystallin by hydrophobic bonds to produce protein aggregates. The purpose of the present study was to use negative-stain transmission electron microscopy (TEM) to investigate peptide/crystallin structures that form when αA 66−80 peptide is incubated with recombinant human (HU) and guinea pig (GP) αA-crystallin, and GP αA ins -crystallin, under physiological conditions of temperature and pH. HU and GP αA-crystallin each consists of 173 amino acid residues with only eight differences. GP αA ins -crystallin contains an insertion of 23 amino acids into the sequence for normal GP αA-crystallin. Synthetic αA 66−80 peptide was incubated with each crystallin for 24 h in phosphate buffered saline at 37 o C, pH 7.4. Samples were loaded onto electron microscopy grids and analyzed by TEM.
Peptide-induced formation of protein aggregates and amyloid fibrils in human and guinea pig αA-crystallins under physiological conditions of temperature and pH hydrophobic bonds to produce protein aggregates. The purpose of the present study was to use negative-stain transmission electron microscopy (TEM) to investigate peptide/crystallin structures that form when αA 66−80 peptide is incubated with recombinant human (HU) and guinea pig (GP) αA-crystallin, and GP αA ins -crystallin, under physiological conditions of temperature and pH. HU and GP αA-crystallin each consists of 173 amino acid residues with only eight differences. GP αA ins -crystallin contains an insertion of 23 amino acids into the sequence for normal GP αA-crystallin. Synthetic αA 66−80 peptide was incubated with each crystallin for 24 h in phosphate buffered saline at 37 o C, pH 7.4. Samples were loaded onto electron microscopy grids and analyzed by TEM.
With GP αA-crystallin, the αA 66−80 peptide appeared to first form up to 700 nm long, independent peptide fibrils, which subsequently bound numerous αA-crystallin oligomers along the entire length of the fibril to form up to 30 nm thick peptide/oligomer fibril structures. In contrast, HU αA-crystallin somehow prevented independent αA 66−80 peptide fibrillation, and instead joined with the peptides to form amorphous aggregates and linear chains of αA oligomers. When incubated alone, GP αA ins -crystallin eventually lost all oligomeric structure and formed amorphous aggregates. However, addition of αA 66−80 peptide to the incubation medium resulted in the formation of highly-organized peptide/αA ins oligomer amyloid fibrils, nearly 400 nm in length, with oligomer dimers appearing to stack one on top of another. Mature peptide/αA ins oligomer fibrils were highly compressed and 40% thicker than observed protofibrils (17 nm vs. 12 nm thickness). Use of a control V72P αA-crystallin peptide, as well as addition of the disulfide bond reducing agent DTT to the incubation medium, prevented fibril formation. Turbidity and Thioflavin T fluorescence analyses confirmed the observed peptideinduced fibril formation. This study represents the first time that fibrillation of αA-crystallin has been accomplished under physiological conditions of temperature and pH without use of denaturants. Fibrillation of GP αA ins
Introduction
A hallmark of the aging human (HU) lens nucleus is the formation of large, abnormal protein aggregates that cause increased lens nuclear light scattering (NLS), leading eventually to nuclear cataract (Datiles et al., 2008; Jedziniak et al., 1973; Thurston et al., 1997) . In this regard, nuclear cataract is one of approximately 40 "protein conformational diseases" (e.g., Alzheimer's disease and Huntington's disease) in which proteins undergo abnormal unfolding followed by aggregation (Chiti and Dobson, 2006; Harding, 1998) . Protein aggregates of a size similar to those associated with HU nuclear cataracts have also been detected in the lens nucleus of guinea pigs (GP's) treated with hyperbaric oxygen (HBO) (Simpanya et al., 2005) . Although age-related lens crystallin aggregation has been studied for many years (Jedziniak et al., 1973; Spector and Roy, 1978) , its mechanism of formation is still not wellunderstood. The high molecular weight (HMW) fraction of HU lenses also contains large amounts of degraded/truncated crystallins with MW's < 18,000 Da (Horwitz et al., 1983; Srivastava, 1988; Srivastava et al., 1996) . Imaging mass spectrometry has revealed in the aging HU lens nucleus the presence of multiple truncation products of α-crystallin (Grey and Schey, 2009) , with crystallin fragments beginning to appear at early middle age (Su et al., 2010) . Convincing evidence has been gathered in recent years indicating that an interaction of low molecular weight crystallin-derived peptides < 3500 Da with intact crystallins may be a key event in age-related protein aggregation occurring in the lens nucleus (Sharma and Santhoshkumar, 2009) .
A major age-related lens peptide found at elevated concentrations in HU nuclear cataracts is the αA 66−80 peptide 66 SDRDKFVIFLDVKHF 80 possessing a MW of 1866 Da (Santhoshkumar et al., 2008 (Santhoshkumar et al., , 2011 . This peptide, which contains a portion of the αA-crystallin chaperone site (residues 70-80) (Sharma et al., 2000) , has also been detected in the lenses of old GP's, and has been observed to increase in concentration following treatment of the animals with HBO (Raju et al., 2015) . The αA 66−80 peptide consists of 15 amino acids, 7 of which are hydrophobic (Fig. 1) . In vitro studies have shown that the peptide can bind to both HU and GP αA-crystallin by hydrophobic bonds to produce "hydrophobic patches" which attract additional crystallins to form HMW aggregates (Kannan et al., 2013; Raju et al., 2015; Santhoshkumar et al., 2011) . In addition, the αA 66−80 peptide is known to possess properties similar to those of β-amyloid peptide, which produces amyloid fibril formation in Alzheimer's disease (Balbach et al., 2000; Raju et al., 2017) . The 70 KFVIF 74 sequence present in the core of the peptide ( Fig. 1) is similar to the 16 KLVFF 20 region of β-amyloid peptide, enabling the peptide to form amyloid fibrils (Kannan et al., 2014; Santhoshkumar et al., 2011) , as well as generate H 2 O 2 (Raju et al., 2017) , when incubated in vitro. It has been known for over a decade that under certain denaturing conditions (e.g., low pH or in the presence of guanidine HCl at 60 o C), each of the lens αA-, αB-, β-and γ-crystallins, as well as aged HU lens crystallin fragments, can assemble into amyloid fibrillar structures (Ghaffari Sharaf et al., 2017; Kosinski-Collins and King, 2003; Meehan et al., 2004 Meehan et al., , 2007 Papanikolopoulou et al., 2008; Sharma and Ghosh, 2017; Srivastava et al., 2017) . Many, perhaps all, polypeptide chains are believed to have a propensity to self-assemble into amyloid fibrils under appropriate conditions (Chiti and Dobson, 2006) . The central, β-sheet structured domain of α-crystallin is believed to be highly susceptible to amyloid fibrillation (Carver et al., 2017) . UV light also has been shown to induce in vitro the formation of highly ordered protein β-sheets in γD-crystallin, typical of β-amyloid secondary structure Moran et al., 2013; Zhang et al., 2017) . However, for some reason, fibrils have not been observed to be present in either normal HU lenses or HU maturity-onset cataracts (Harding, 1972; Meehan et al., 2004) . It is possible that the environment of the human lens, including perhaps the chaperone-like function of α-crystallin (Ecroyd and Carver, 2009; Horwitz, 1992) , may act to inhibit crystallin fibril formation. α-crystallin is the major protein in the lens, accounting for approximately 40% of the total protein content (Horwitz et al., 1999) . In the intact lens, α-crystallin consists of both αA and αB subunits at a ratio of 3:1. The α-crystallin complex ranges between 600 and 900 kDa in molecular weight, being comprised of between 30 and 45 subunits, although studies conducted with both bovine αB-crystallin (Aquilina et al., 2003) and individual recombinant HU αA-and αB-crystallins (Peschek et al., 2009 ) have indicated a polydispersity of oligomeric forms. Other studies have suggested that αA-crystallin may play a relatively more important role than αB in maintaining lens transparency since a knockout of αA-crystallin in the mouse lens lead to severe cataract, while deletion of αB-crystallin produced no lens phenotype (Brady et al., 1997 (Brady et al., , 2001 ). As mentioned above, αA-crystallin is capable of forming amyloid fibrils under denaturing conditions, and the agerelated αA-crystallin fragment αA 66−80 peptide can bind to αA-crystallin to produce HMW aggregates, as well as form amyloid fibrils independently. All of this information emphasizes the need for conducting a detailed investigation and characterization of the interaction A. Kumarasamy et al. Experimental Eye Research 179 (2019) 193-205 of αA 66−80 peptide with αA-crystallin oligomers, as we have done in the current study with the use of negative-stain transmission electron microscopy (TEM), a common method for visualizing amyloid fibrils in vitro (Meehan et al., 2004; Tosoni et al., 2011 (Yang et al., 2015) . HU and GP αA-crystallin each contain 173 amino acids with eight amino acid differences between the two sequences ( Fig. 1) . One potentially important difference is the presence of two cysteine -SH groups in the sequence of HU αA-crystallin, compared to just one in the GP protein. αA ins -crystallin is a protein produced by evolutionary alternative splicing which exists in the lenses of a number of rodent species including rat, mouse, and pika, and a few non-rodent mammals such as GP, kangaroo, hedgehog and bat, but not in species such as rabbit, dog and primates (Hendriks et al., 1988; van Dijk et al., 2001) . αA ins -crystallin mRNA has been found in both the epithelium and fibers of mouse lenses at levels of 10-20 percent of total αA-crystallin mRNA (King and Piatigorsky, 1984) . GP αA ins -crystallin contains an insertion of 23 amino acids between residues 63 and 64 to produce a total of 196 amino acids, compared to 173 for the normal crystallin ( Fig. 1) . It is unclear why αA ins -crystallin has been retained in the lenses of certain species for over 70 million years of evolution, especially since the protein has been shown to possess reduced chaperone-like activity compared with that of normal αA-crystallin (Smulders et al., 1995) . As a control for the αA 66−80 peptide, a V72P αA-crystallin peptide in which proline was substituted for valine at residue 72 was employed. Although the V72P peptide binds to some extent to αA-crystallin, it has been shown to lack the β-sheet structure of αA 66−80 peptide, and thus does not form fibrils when incubated alone (Kannan et al., 2014) . This study has demonstrated for the first time that αA 66−80 peptide under non-denaturing conditions of temperature and pH is able to induce the formation of two very different types of fibrils in GP αA-and αA inscrystallins, while inducing amorphous aggregate formation in HU αA-crystallin.
Materials and methods

Materials
The two peptides employed in the study, αA 66−80 peptide (SDRD-KFVIFLDVKHF) and control V72P peptide (SDRDKFPIFLDVKHF), were obtained at > 95% purity from GenScript (Piscataway, NJ, U.S.A.). Bovine γD-crystallin was obtained from Enzo Life Sciences (Farmingdale, NY, U.S.A.). All other reagents were from Sigma-Aldrich (St. Louis, MO, U.S.A.) unless otherwise specified.
Creation of wild type and mutant HU and GP αA-crystallin
Wild type (WT) HU αA-crystallin of 173 amino acids was overexpressed using a pET23d expression vector (EMD Millipore, Novagen, Billerica, MA, U.S.A.). Mutant HU C142S αA-crystallin, with a substitution of one cysteine at residue 142, was created with primers designed by NEBaseChanger™, online software for primer design, and with a Q5 Site-Directed Mutagenesis Kit from New England Biolabs (NEB, Ipswich, MA, U.S.A.). The gene for GP αA ins -crystallin, containing an insert of 23 amino acids in the region from residue 63 of WT GP αA-crystallin, was synthesized by Genscript (Piscataway, NJ, U.S.A.) and cloned into a pET28a expression vector between the NcoI and XhoI restriction sites. A plasmid system for expression of normal WT GP αA-crystallin of 173 amino acids was created by deletion of the 69 base pair insert in the GP αA ins -crystallin gene with primers designed with NEBaseChanger™, and with use of a Q5 Site-Directed Mutagenesis Kit from NEB. An S142C mutant of GP αA-crystallin, containing two cysteines rather than the one present in the WT protein, was created in a similar manner. All plasmid constructs used were sequenced to confirm identity (Supplemental Fig. 1 -crystallin, only the 10% of the protein that remained in the supernatant (the rest being present in the pellet) was purified and used for experiments. Efforts to unfold the WI crystallin in 6M urea and refold by dialysis against water or buffer were unsuccessful in solubilizing the protein, as had previously been done for rat αA ins -crystallin (Smulders et al., 1995) . The supernatant was loaded onto a Buffer A-pre-equilibrated Highprep-DEAE-Fast Flow resin column (GE Healthcare Bio-Sciences, Pittsburgh, PA, U.S.A.) and eluted with a gradient of Buffer B (20 mM TrisHCl, pH 8.0, 1000 mM NaCl, 0.5 mM TCEP, 5% (v/v) glycerol). The eluted fractions were analyzed by 12% (w/v) SDS-PAGE and fractions containing prominent amounts of each protein of interest were pooled, concentrated using centrifugal filters, and loaded on to a Sephacryl S300 size exclusion chromatography column (GE Healthcare Bio-Sciences, Pittsburgh, PA, U.S.A.) that had been pre-equilibrated with phosphate buffered saline (PBS, 137 mM NaCl, 10 mM phosphate, 2.7 mM KCl), pH 7.4. Eluted fractions from the size exclusion column containing the protein of interest were verified by 12% (w/v) SDS-PAGE. Fractions having maximum purity were pooled and their concentration determined using a Pierce BCA protein assay kit (ThermoFisher Scientific, Rockford, IL, U.S.A.).
HPLC and SDS-PAGE analysis
Purified recombinant αA-crystallin proteins were injected on to an HPLC system (Shimadzu Scientific Co., Kyoto, Japan) with a size exclusion column (Biosep-SEC-S4000; Phenomenex, Torrance, CA, U.S.A.) equilibrated with PBS, pH 7.4. The flow rate was 1 ml/min and the column was attached to a UVB (280 nm wavelength) detector. The column was calibrated with the following protein standards and molecular weights (MWs): Blue dextran (2000 kDa), thyroglobulin (660 kDa), apoferritin (443 kDa), β-amylase (200 kDa), bovine serum albumin (66 kDa), and carbonic anhydrase (29 kDa). MWs of αA-crystallin oligomers were estimated from their HPLC elution times. The logs of the MW standards were plotted against elution time, and Excel was used to generate a linear trend line and corresponding equation. The peak elution time of each αA-crystallin oligomer was used in the equation to solve for kDa MW. Purified αA-crystallins were analyzed by 12% SDS-PAGE after reduction of disulfide in a 4x SDS gel sample buffer 0.5 M Tris/HCl, pH 6.8, containing 20% glycerol [vol/vol] , 20% SDS, 1% bromophenol blue, and 50 mM DTT (Laemmli, 1970) . Samples were boiled at 95 to 97 o C for 5 min and 10 μg loaded into each well.
The gel was run at a constant current of 20 mA until the bromophenol blue dye was a few millimeters from the end, followed by Coomassie Brilliant Blue staining. MW markers were from Gold Biotechnology, Inc.
(St. Louis, MO, U.S.A.).
Prediction of secondary structures of αA-crystallin and peptides
Amino acid sequences of HU and GP αA-crystallin, as well as αA 66−80 and V72P peptides, were submitted to an online server (I-TASSER; http://zhanglab.ccmb.med.umich.edu/I-TASSER/) to predict secondary structures, which were represented for visualization of β-sheets present in the structures. A Zyggregator (Tartaglia et al., 2008) program was employed for predicting aggregation and fibril-forming propensities of HU and GP αA-crystallin.
Transmission electron microscopy (TEM)
In order to visualize morphological effects on lens crystallins following incubation of the proteins with either αA 66−80 or control V72P
peptide, negative-stain TEM was employed. Protein (0.25 mg/ml) and peptide (0.05 mg/ml) were incubated together in PBS, pH 7.4, 20 μl volume, 37 o C, for 24 h. At the end of the incubation period, 10 μl of sample was loaded on to a 400 mesh Formvar carbon-coated copper electron microscopy grid (Electron Microscopy Sciences, Hatfield, PA, U.S.A) as described earlier (Raju et al., 2012) with slight modification. GP αA-crystallin, HU αA-crystallin, and GP αA ins -crystallin were also incubated alone for 0 and 24 h, and analyzed by TEM. Zero time samples were centrifuged first [14,000 rpm (20,817g) for 10 min], but 24 h samples were not. After loading each sample, the grid was washed with 10 μl of deionized water, negatively stained with 10 μl of 2% w/v aqueous uranyl acetate, and then washed again with 10 μl of deionized water. After 1 h, samples were viewed with use of an FEI Morgagni 268 TEM at either 80 or 100 kV. For determination of fibril and oligomer diameters, an ImageJ software package was employed (Schneider et al., 2012) . Diameters of light areas were measured at the inner borders of darkly stained regions which surrounded the electron lucent structures of interest. Commands employed were the straight line tool and analyze/measure function. Data were calibrated using scale bars (nm) on the images with the analyze/set scale function of ImageJ. Measurements were collated and analyzed using Microsoft Excel for mean and standard deviation (S.D.).
Turbidity and supernatant protein analysis
Turbidity analyses were conducted at a wavelength of 400 nm to evaluate peptide, crystallin, and crystallin/peptide aggregation and fibril formation in vitro. Briefly, a 100 μl mixture of protein (0.25 mg/ml) and peptide (0.05 mg/ml) in PBS, pH 7.4, 37 o C, at 0 and 24 h incubations were added to a 96-microwell plate, and absorbance measured at 400 nm wavelength using a BioTek Cytation 3 reader (BioTek Instruments, Inc., Winooski, VT, U.S.A.). Each sample mixture was centrifuged at 14,000 rpm (20,817g) for 10 min, and the supernatant analyzed for protein concentration using a Pierce BCA protein assay kit (ThermoFisher Scientific, Rockford, IL, U.S.A.). Results were expressed as the mean ± S.D. for three separate experiments.
Thioflavin T fluorescence
Thioflavin T (ThT) fluorescence was measured using an RF-6000 Shimadzu spectrofluorophotometer (Shimadzu, Columbia, MD, U.S.A.). ThT is an amyloid detection dye whose fluorescence increases after binding to amyloid fibrillary aggregates. In order to assess fibril formation, 20 μl aliquots of samples were taken from 0 to 24 h incubations of proteins (0.25 mg/ml) and peptides (0.05 mg/ml) and mixed with ThT to a final concentration of 16 μg/ml. Fluorescence emission spectra were measured at a wavelength range of 450-500 nm (445 nm excitation). An increase in fluorescence emission intensity at 486 nm (Wang et al., 2010) was taken as an indication of amyloid fibril formation. 
Statistics
Results
HPLC and SDS-PAGE analysis
Four of the five purified recombinant αA-crystallins investigated in the study (GP, mutant GP S142C, HU and mutant HU C142S) eluted at A. Kumarasamy et al. Experimental Eye Research 179 (2019) 193-205 about the same time period during HPLC analysis (each peak at approximately 9 min) ( Fig. 2A) . A linear fit of the data to MW standards yielded peak MWs of 496 and 486 kDa for GP and HU αA-crystallin, respectively, corresponding to 25 and 24 subunits per oligomer. In contrast, purified recombinant GP αA ins -crystallin lost its organized oligomer structure during passage through the HPLC column, exhibiting mainly monomers with some higher MW species ( Fig. 2A) .
Results of SDS-PAGE analysis of the five purified recombinant αA-crystallins are shown in Fig. 2B . The MW of αA ins -crystallin is 22,476 Da, which compares to about 20,000 Da for the other αA-crystallins.
TEM analysis of αA 66−80 and V72P peptides
TEM analysis was conducted to determine whether αA 66−80 and control V72P peptides would form amyloid fibrils under the experimental conditions employed in the current study. I-TASSER analysis indicated the presence of β-sheet structure for αA 66−80 but not V72P peptide (Fig. 3A) . The peptides (0.05 mg/ml) were incubated separately in PBS, pH 7.4, at 37 o C. After 24 h, αA 66−80 peptides had formed long, rigid fibrils of up to 1 μm in length (Fig. 3B) . Addition of 50 mM DTT to the incubation medium resulted in the production of αA 66−80 peptide fibrils similar to those formed in the absence of DTT, with no major structural differences (Fig. 3C ). In contrast, V72P peptides showed no evidence of fibril formation after 24 h of incubation (Fig. 3D) .
Turbidity and supernatant analysis
Turbidity analysis was conducted at a wavelength of 400 nm in order to evaluate peptide, crystallin, and crystallin/peptide aggregation and fibril formation at 0 and 24 h of incubation (Fig. 4A) . This type of analysis is frequently employed for assessing the extent of protein aggregation and amyloid fibril growth (Chaudhuri et al., 2014; Hall et al., 2016; Zhao et al., 2016) . αA 66−80 peptide, as well as recombinant GP and HU αA-crystallin, each showed only slight turbidity at 0 and 24 h when incubated alone (Fig. 4A) . In contrast, when the peptide was mixed with either of the two crystallins, turbidity was observed to increase significantly at 0 time (p < 0.05), and to increase further after 24 h (p < 0.01). GP αA ins -crystallin by itself exhibited considerable turbidity at 0 time, and this increased three-fold at 24 h (Fig. 4A) . The 0 time value more than doubled following the addition of αA 66−80 peptide (p < 0.05), and although the 24 h value increased by more than 50%, the increase was not statistically significant compared to that for protein alone. Incubation of the αA 66−80 peptide with γD-crystallin showed only slight turbidity, which may have been the result of selfaggregation of the peptide. Similarly, incubation of control V72P peptide with either GP or HU αA-crystallin, or with GP αA ins -crystallin, produced an insignificant elevation in turbidity at the two time periods, compared with values for protein alone (Fig. 4A) . Following turbidity analysis, each solution was centrifuged and the concentration of protein remaining in the supernatant was measured in order to determine the percentage of soluble protein that had aggregated and precipitated. GP αA-crystallin plus αA 66−80 peptide incubated for 24 h showed a 12% loss of WS protein compared to incubation of the protein alone (p < 0.05). However, loss of HU αA-crystallin when incubated with the peptide for the same time period was not statistically different from the value for the crystallin alone (Fig. 4B) (Fig. 4B) .
TEM analysis of recombinant GP αA-crystallin incubated with peptides
Results of studies described above indicated that αA 66−80 peptide binds to GP αA-crystallin in vitro to produce protein aggregates, some of which become WI ( Fig. 4A and B) . In order to view the aggregates and determine whether formation of either amorphous aggregates or ordered fibrils had occurred, TEM analysis was conducted. The protein was incubated in PBS at 37 o C, with and without αA 66−80 or V72P peptide, and aliquots of the mixtures were spotted on Formvar and carbon-coated copper grids, and analyzed. Incubation of GP αA-crystallin by itself for either 0 or 24 h showed the presence of independent αA-crystallin oligomers with an average diameter of 10 ± 3 nm ( Fig. 5A and B, respectively). The oligomers possessed a well-defined shape and were homogeneously distributed. Based on the results of HPLC analysis ( Fig. 2A) , the average recombinant GP αA oligomer would consist of 25 subunits with a MW of 496 kDa. Incubation of αA 66−80 peptide with GP αA-crystallin protein for 24 h showed the presence of independent αA-crystallin oligomers (Fig. 5C , large arrows without tails) along with what appeared to be a nearly 300 nm long, 9 ± 3 nm thick, peptide fibril (Fig. 5C, arrowhead, #1 ), similar to the αA 66−80 peptide fibril shown in Fig. 3B . In addition, three apparent peptide fibrils with bound αA-crystallin oligomers, 200-300 nm in length, with varying thicknesses of 25 ± 11 nm, 11 ± 3 nm and 21 ± 8 nm, can be observed (Fig. 5C , arrows with tails, #'s 2, 3 and 4, respectively). Nineteen additional fibrils were measured in three additional micrographs from the experiment of Fig. 5C , and the thicknesses ranged from 5 to 75 nm. It appears that peptide fibrils may have formed first, followed by the binding of GP αA-crystallin oligomers to form increasingly thick peptide/crystallin oligomer fibrils. This type of scenario is suggested by the varying thicknesses of fibril #2 in Fig. 5C , which range from 12 to 40 nm. Additional TEM evidence for this type of mechanism in which the peptide fibril forms first is contained in Supplemental Fig. 2A which shows a highly tapered αA 66−80 peptide/GP αA oligomer fibril that is nearly 700 nm long (fibril #2). While the base of the fibril is only 2.4 nm thick, and presumably consists of bare peptide fibril, the upper portion is 21 nm thick and represents peptide fibril with bound αA oligomers. Apparent gaps in fibrils located between bound oligomers are also evident (Supplemental Fig. 2 A-E), suggesting a random binding of oligomers. A few possible disulfide cross-linked oligomers can be seen in Figs. 5C and 7G (small arrows). A possible scheme for the binding of GP αA-crystallin oligomers to αA 66−80 peptide fibrils is shown in Fig. 5D . In contrast to the results shown in Fig. 5C , incubation of V72P peptide with the crystallin for 24 h produced no evidence of any fibril formation (Fig. 5E ). Incubation of αA 66−80 peptide with bovine γD-crystallin for 24 h also produced no type of aggregate ( Fig. 5F ), compared with the control (Fig. 5G ).
In view of the fact that intermolecular protein disulfide has been linked with amyloid fibril formation (Herrmann and Caughey, 1998; Welker et al., 2001) , an experiment was conducted in which the disulfide bond reducing agent DTT was incubated with αA 66−80 peptide and GP αA-crystallin for 24 h. TEM analysis indicated that under these conditions, extensive binding of αA-crystallin oligomers to independent αA 66−80 peptide fibrils was not observed (Fig. 5H) , as it had been without use of DTT (Fig. 5C) . While a few apparent thin peptide fibrils are visible in Fig. 5H (arrows), addition of DTT prevented the formation of peptide/αA-crystallin oligomer fibrils. To test whether just a single crystallin -SH group in GP αA-crystallin might be required for fibril formation, mutant GP S142C αA-crystallin (with two -SH groups instead of one) was incubated with αA 66−80 peptide for 24 h. TEM analysis indicated that under this condition, the peptide was not able to induce amyloid fibril formation with the crystallin (Fig. 5I) . Two other GP αA-crystallin mutants, A13T and G153T, were also tested for their ability to form fibrils when incubated with αA 66−80 peptide. TEM analysis for each of the mutants also showed no evidence of fibril formation after 24 h of incubation with the peptide (Supplemental Fig. 3 ).
TEM analysis of recombinant HU αA-crystallin incubated with peptides
HU αA-crystallin, with an amino acid sequence differing from the GP protein by only eight residues (Fig. 1) , also exhibited protein aggregation when incubated with αA 66−80 peptide (Fig. 4A) . In order to determine the nature of the aggregates, TEM analysis was conducted. Incubation of the crystallin by itself for 0 and 24 h produced independent αA-crystallin oligomers, 11 ± 3 nm in diameter ( Fig. 6A and B, large arrows). Similar to the observed GP αA-crystallin oligomers ( Fig. 5A and B) , HU αA-crystallin oligomers were well-defined and homogeneous in distribution with certain images revealing an apparent opening to the interior of the structure (Fig. 6B , small arrows and inset), as has been reported previously for recombinant HU αB-crystallin (Peschek et al., 2009) . Based on HPLC analysis ( Fig. 2A) , the average HU αA-crystallin oligomer would consist of 24 subunits with a MW of 486 kDa. When HU αA-crystallin was incubated with αA 66−80 peptide for 24 h, the presence of linear chains of oligomers, presumably bound together by peptides, was observed, along with small clusters of oligomer aggregates (Fig. 6C ), but without formation of fibrils as had been seen for GP αA-crystallin plus αA 66−80 peptide (Fig. 5C ). Linear polymers of human α-crystallin have been observed previously in TEM micrographs (Augusteyn et al., 1989) . When HU αA-crystallin was . GP: guinea pig; HU: human; *: p < 0.05 compared to the protein by itself. **: p < 0.01 compared to the protein by itself. Error bars represent S.D. for three independent biological repeats. The lack of a visible error bar indicates that the error was too small to be seen.
A. Kumarasamy et al. Experimental Eye Research 179 (2019) 193-205 incubated with control V72P peptide, or with αA 66−80 peptide in the presence of DTT, each for 24 h, the formation of oligomer chains and well-defined aggregates was substantially diminished ( Fig. 6D and E, respectively). To test whether the presence of only a single crystallin -SH group in HU αA-crystallin, instead of two -SH groups, might lead to peptide-induced fibril formation as was seen for GP αA-crystallin (Fig. 5C ), mutant HU C142S αA-crystallin was incubated with αA 66−80 peptide for 24 h. TEM analysis indicated that under this condition, the peptide was not able to induce fibril formation with the crystallin (Fig. 6F) ; the result was similar to that observed for αA 66−80 peptide plus WT HU αA-crystallin (Fig. 6C) .
TEM analysis of recombinant GP αA ins -crystallin incubated with peptides
Turbidity and supernatant analyses described above (Fig. 4) had indicated that WI protein aggregates form when GP αA ins -crystallin is incubated either alone or with αA 66−80 peptide for 24 h. TEM analysis was conducted to determine whether amorphous aggregates or structured fibrils form under those conditions. Incubation of GP αA ins -crystallin at time 0 showed the presence of independent oligomers with a mean diameter of 8 ± 1 nm (Fig. 7A) . In contrast to the TEM results for GP and HU αA-crystallins at time 0 (Figs. 5A and 6A, respectively), the GP αA ins -crystallin oligomers exhibited imperfect boundaries with variation in size and shape at the same time point (Fig. 7A) . Following 24 h of incubation, the crystallins lost their oligomeric structure and formed clustered protein aggregates (Fig. 7B) , also in contrast to the results for GP and HU αA-crystallins at the same time period (Figs. 5B and 6B, respectively) . Surprisingly, when αA 66−80 peptide was included in the incubation mixture with αA ins -crystallin for 24 h, the peptide was seen to induce the formation of highly-structured peptide/ oligomer protofibrils and compressed, mature fibrils up to nearly 400 nm in length (Fig. 7C, F and 9 ). The average thickness of a protofibril was 12 ± 1 nm (14 fibrils were measured in three micrographs of one experiment) and that of a mature fibril 17 ± 1 nm (6 fibrils were measured in two micrographs of one experiment). The darker staining of the mature fibril at the borders, with lighter staining within the interior regions (Fig. 7F) , suggests the existence of a tubule. When αA 66−80 peptide was replaced with V72P peptide for the 24 h incubation, amorphous aggregates were detected, with no fibrils (Fig. 7D) . Inclusion of DTT in the incubation mixture containing αA 66−80 peptide and GP αA ins -crystallin also prevented formation of the peptide/oligomer fibrils (Fig. 7E) . A comparison of the highly-structured, mature peptide/GP αA ins -crystallin oligomer fibril with the more randomlyformed peptide/GP αA-crystallin oligomer fibril is shown in Fig. 7F and G, respectively.
Since the fibrillary nature of a protein is associated with its β-sheet content, β-sheet percentage values for the three HU and GP αA-crystallins were determined using I-TASSER analysis (Table 1) . The results indicated 34%, 33% and 30% β-sheet for GP αA-, HU αA-and GP αA inscrystallin, respectively.
The 23 inserted amino acid sequence LMTHMWFVMHQPHAGNP-KNNPAK of GP αA ins -crystallin was further analyzed with use of an online Zyggregator (Tartaglia et al., 2008) program which revealed that the HMWFV continuous stretch of hydrophobic acids in the sequence (residues 67-71) possessed a high probability for fibril formation (a Z agg score > 2, where a score > 1 indicates a high propensity to form fibrils) (Supplemental Fig. 4) . Similar results were obtained with use of AmylPred2 (Tsolis et al., 2013) and FoldAmyloid programs (Garbuzynskiy et al., 2010 ) (data not shown).
Thioflavin T (ThT) fluorescence analysis
To further investigate peptide/αA oligomer amyloid fibril formation, ThT fluorescence was measured after incubating αA 66−80 and V72P peptides with recombinant αA-crystallins for 0 and 24 h (Fig. 8) .
ThT selectively localizes to β-sheet-rich structures such as those present in amyloid fibrils to produce an increase in fluorescence brightness (Biancalana and Koide, 2010) . When αA 66−80 peptide, which had previously been shown by TEM analysis to form β-amyloid fibrils (Fig. 3B) , was incubated alone for 24 h, it exhibited a nearly ten-fold higher level of ThT fluorescence than that for V72P peptide (p < 0.01) (Fig. 8) . Since αA 66−80 peptide is itself fibrillogenic, the decision was made to analyze the ThT fluorescence data by comparing the value for each crystallin plus peptide to the sum of the individual values for crystallin and peptide. The fluorescence produced by incubating αA 66−80 peptide with bovine γD-crystallin or GP and HU αA-crystallin for 24 h was actually lower than that for the sum of the individual values for peptide and protein (Fig. 8) . In sharp contrast, the for three biological repeats. The lack of a visible error bar indicates that the error was too small to be seen. A. Kumarasamy et al. Experimental Eye Research 179 (2019) 193-205 fluorescence produced by incubation of GP αA ins -crystallin with found by TEM analysis to produce only amorphous protein aggregates after 24 h, without formation of fibrils (Fig. 7D ). This result may have been due to possible interaction of the amyloidogenic region of GP αA ins -crystallin (Supplemental Fig. 4 ) with hydrophobic amino acids present in V72P peptides, exposing β-sheet-rich structures to yield increased ThT fluorescence.
Discussion
This study has demonstrated for the first time the generation of β-amyloid fibrils from a full length lens crystallin protein, GP αA inscrystallin, incubated under physiological conditions of pH and temperature without use of denaturants (Fig. 7C) . Earlier investigations required destabilizing conditions of either low pH or high temperature in order to induce α-, β-and γ-crystallin fibril formation (Ghaffari Sharaf et al., 2017; Meehan et al., 2004 Meehan et al., , 2007 Papanikolopoulou et al., 2008; Sharma and Ghosh, 2017; Wang et al., 2010) . Indeed, few fibrillation studies of any proteins have been conducted at physiological pH (Yang et al., 2015) . The induction of GP αA ins -crystallin fibrils was accomplished by incubating the protein with αA 66−80 peptide, which forms naturally in the aging lens nucleus and binds to αA-crystallin (Kannan et al., 2013; Raju et al., 2015; Santhoshkumar et al., 2008; Su et al., 2010) . The lengths of the fibrils of up to 400 nm (Fig. 7C) are typical of amyloid fibril lengths (Gillam and MacPhee, 2013) , and the fibrillation process appeared to be highly organized with classic elongation as is characteristic of amyloid fibril formation (Rambaran and Serpell, 2008) . To the best of our knowledge, only one other study has reported fibrillation of αA-crystallin, and that was achieved by incubating HU αA-crystallin under denaturing conditions at 60 o C (Meehan et al., 2007) . This study also revealed the tendency of αA 66−80 peptides to first form independent peptide fibrils in the presence of GP αA-crystallin, preceding a random binding of crystallin oligomers to the fibrils, presumably by hydrophobic bonds, to produce 200-700 nm long peptide/ oligomer fibrils ( Fig. 5C ; Supplemental Fig. 2 ). It might be argued that GP αA-crystallin oligomers became bound to αA 66−80 peptide fibrils in a chaperone-like manner in an attempt to prevent further elongation of the fibrils. A similar capability of fibril growth inhibition has been reported for HU αB-crystallin with amyloid-β and αA-synuclein fibrils (Narayan et al., 2012; Raman et al., 2005; Shammas et al., 2011; Stege et al., 1999; Waudby et al., 2010; Wilhelmus et al., 2006) . αB-crystallin was shown to bind to the entire length and ends of amyloid-β peptide fibrils as an effective method of inhibiting fibril proliferation (Shammas et al., 2011) . Results of a previous study demonstrated the toxic ability of certain fibril-forming peptides to aggregate with each other, as well as with other cellular proteins (Olzscha et al., 2011) . The fact that independent αA 66−80 peptide fibril formation did not take place when the peptide was incubated with either HU αA-or GP αA ins -crystallins may be related to the relative affinities of the peptide for the different crystallins. αA 66−80 peptide was clearly able to bind to HU αA-crystallin to form amorphous aggregates as evidenced by turbidity and TEM analyses (Figs. 4A and 6C, respectively) . Although the binding sites of this peptide to αA-crystallin are not known, the peptide has been reported to attach to αB-crystallin at the C-terminal region (residues 164-174), as well as at and near the chaperone site (residues 73-92) (Kannan et al., 2013) . These sites may be more or less exposed in different αA-crystallins. It is not entirely clear why αA 66−80 peptide was able to form peptide/oligomer fibrils with GP αA-crystallin (Fig. 5C ), but not with the HU protein (Fig. 6C) , despite the fact that both crystallins are comprised of 173 amino acids with only eight residue differences (Fig. 1) . Mutant GP S142C αA-crystallin, with two -SH groups instead of one (matching the HU protein), lost its ability to form fibrils with the peptide (Fig. 5I) . However, mutant HU C142S αA-crystallin, with one -SH crystallin instead of two (matching the GP protein), failed to gain the ability to form peptide/oligomer fibrils (Fig. 6F) . Two other GP αA-crystallin mutants, A13T and G153T, were also unable to form fibrils with the peptide (Supplementary Fig. 3 ). It is possible that the entire 173 amino acid structure of GP αA-crystallin may be required for fibril formation with αA 66−80 peptide.
Results for turbidity and supernatant analyses ( Fig. 4A and B, respectively), and ThT fluorescence analysis (Fig. 8) , matched the observed TEM data (Figs. 5C, 6C and 7C). These techniques have been employed previously to investigate αA-and αB-crystallin amyloid fibril formation (Meehan et al., 2007) . The combination of αA 66−80 peptide incubation with GP αA-, HU αA-or GP αA ins -crystallin for 24 h each produced increases in turbidity, indicative of either aggregate or fibril formation (Fig. 4A) . Supernatant analysis at the 24 h time point revealed either insoluble aggregate or fibril formation for GP αA-and αA ins -crystallins, but only soluble aggregation of HU αA-crystallin without precipitation (Fig. 4B ), all of which was supported by subsequent TEM analysis. ThT fluorescence analysis (Fig. 8 ) also confirmed the TEM micrograph results indicating αA 66−80 peptide/crystallin amyloid fibril formation for GP αA ins -crystallin, but not for γD-crystallin and GP and HU αA-crystallins. The mechanism involved in the compression of 12 nm thick GP αA ins -crystallin protofibrils into 17 nm thick mature fibrils (Fig. 7C ) is unclear; however, hydrophobic forces sufficient to pull the peptide/ oligomer structures together were presumably involved. It was unexpected to learn by means of I-TASSER analysis that the β-sheet content of GP αA ins -crystallin was actually lower than that for both HU and GP αA-crystallin (Table 1) . Presumably, the high propensity for this crystallin to form fibrils with αA 66−80 peptide is associated to a large extent with the hydrophobic HMWFV sequence present in the 23 amino acid insert, which yielded a Z agg score > 2 (Supplemental Fig. 4 ). It can be speculated that the trigger that resulted in the unique formation of αA 66−80 peptide/GP αA ins -crystallin oligomer fibrils may have been hydrophobic binding of peptide to the HMWFV sequence present in the insert. The disulfide bond reducing agent DTT was found to prevent αA 66−80 peptide-induced formation of both peptide/GP αA-crystallin fibrils ( Fig. 5H ) and peptide/αA ins -crystallin fibrils (Fig. 7E) ; however, the related mechanisms, and whether disulfide reduction may or may not actually be involved, are not completely clear at this time. Considerable evidence exists to support a role for intermolecular disulfide in the formation and stabilization of certain amyloid fibrils (Fei and Perrett, 2009; Herrmann and Caughey, 1998; Lee and Eisenberg, 2003; Ohhashi et al., 2004; Welker et al., 2001 ). However, αB-crystallin, which is completely devoid of -SH groups, is also capable of forming fibrils under denaturing conditions (Meehan et al., 2004 (Meehan et al., , 2007 . A possible key factor in the current study is that αA 66−80 peptide is (Raju et al., 2017) , and thus this peptide would presumably be able to indirectly oxidize crystallin -SH groups during the incubations. Oxidation of HU αA-crystallin with its two -SH groups would have produced intramolecular, and not intermolecular, disulfide as has been documented to occur in HU nuclear cataracts (Takemoto, 1996) . This difference may explain why HU αA-crystallin did not form fibrils with αA 66−80 peptide (Fig. 6C ). Since both GP αA-and αA ins -crystallins contain only a single -SH group per subunit, an oxidative environment would produce disulfide-crosslinked oligomer dimers for these two crystallins. It can be speculated that the stacking of GP αA ins -crystallin oligomer dimers one on top of the other in the observed protofibrils (Fig. 9 ) may have occurred via disulfidecrosslinking of single -SH groups present in the crystallin subunits (disulfide-crosslinked dimers of GP αA ins -crystallin, but not of HU αA-crystallin, can be seen in the SDS-PAGE gels of Supplemental Fig. 5 ). Similar disulfide-crosslinked oligomer dimers have been observed in acetylcholine receptors from southern ocean electric fish (Tierney et al., 2004) . Although DTT did not appear to have any major effects on the fibrillation of individual αA 66−80 peptides (Fig. 3C) , it cannot be ruled out that the agent was able to block fibril formation (Figs. 5H and 7E) via some non-disulfide-reducing mechanism. A variety of small molecules are known to inhibit fibrillation by affecting β-amyloid oligomerization, fibrillation or both (Necula et al., 2007; Porat et al., 2006) . Fibrillation of αA 66−80 peptide itself was inhibited by epigallocatechin-3-gallate (Kumar et al., 2017) and fibrillation of HU γD-crystallin and bovine α-crystallin under denaturing conditions was blocked by certain dyes (Sharma and Ghosh, 2017) , as well as by carnosine (Attanasio et al., 2009) , respectively. In addition to reducing protein disulfide, DTT is known to interact with domains of proteins that lack cysteine residues (Alliegro, 2000) , and thus the molecule may have been able to interfere with fibrillation via hydrogen bonding to the GP αA-crystallins. The observed inability of αA 66−80 peptide to generate fibrils with HU αA-crystallin (Fig. 6C ) matches with reports that fibrils are not present in HU maturity-onset cataracts (Harding, 1972; Meehan et al., 2004) , although they have been detected in lenses of Alzheimer's and Down syndrome patients (Goldstein et al., 2003; Moncaster et al., 2010) . However, αA 66−80 peptide did cause aggregation of HU αA-crystallin (Figs. 4A and 6C), which is a hallmark of HU nuclear cataract (Srivastava et al., 2008) , and thus this result is supportive of a role for this peptide in HU nuclear cataract formation. It is of interest that in contrast to HU maturity-onset cataracts, amyloid fibrils have been detected in cataractous lenses of the OXYS strain of rats (Marsili et al., 2004) , possibly due in part to the fact that rat αA-crystallin contains just a single -SH group and would thus be able to form intermolecular disulfide under oxidative stress. In the current study, GP αA ins -crystallin exhibited imperfect oligomeric structures during incubation at time 0 (Fig. 7A) , and subsequently lost all multimeric structure, breaking apart to form independent monomers and amorphous aggregates ( Figs. 2A and 7B ). In contrast, other investigators have reported no substantial differences in morphology, multimerization or stability between recombinant rat αA-and αA ins -crystallins (Smulders et al., 1995) . This is surprising since there are only two amino acid sequence differences between rat and GP αA ins -crystallin (at residues 85 and 113). Whereas in the previous study, rat αA ins -crystallin was isolated only from the WI fraction of the αA ins cell lysate after unfolding the protein in 6M urea and refolding by dialysis against water or buffer, this technique did not work in our hands for the GP αA ins -crystallin (the protein remained insoluble). Thus, all of the current work was completed only with the 10% GP αA ins -crystallin protein remaining in the WS cell lysate fraction.
αA 66−80 peptide is known to be present in the old GP lens and to increase in concentration when the animals are treated with HBO (Raju et al., 2015) . However, whether the peptide is able to form independent peptide fibrils or induce fibrillation of αA ins -crystallin in the intact GP lens, as was observed in vitro in this study (Figs. 5C and 7C, respectively) , is not known. Although HBO-treatment of GP's produces an increase in the level of disulfide-crosslinked protein aggregates in the lens nucleus (Simpanya et al., 2005) , whether these aggregates might contain αA ins -crystallin amyloid fibrils has not been investigated.
Conclusions
This is the first time that an α-crystallin, namely GP αA ins -crystallin, has been induced to form amyloid fibrils without the use of denaturants. The triggering factor may have been hydrophobic binding of αA 66−80 peptide to the highly fibrillogenic HMWFV stretch of residues present in the 23 amino acid insertion region of the protein. The existence of a single -SH in the crystallin may have permitted disulfidecrosslinking of αA ins oligomer pairs, which appeared to stack one on top of another in observed peptide/αA ins oligomer protofibrils. In the presence of normal GP αA-crystallin, αA 66−80 peptides formed long, independent amyloid fibrils, possibly due to a relatively low affinity of the peptide for the crystallin. The subsequent binding of GP αA-crystallin oligomers to independent peptide fibrils may have been associated with a chaperone-like activity of the crystallin. The observed αA 66−80 peptide-induced formation of HU αA-crystallin protein aggregates, without fibrillation, supports a role for this age-related lens peptide in the formation of HU nuclear cataract, and is in line with previous reports of an absence of fibrils in HU maturity-onset cataracts.
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